QuidelOrtho Corp (QDEL)
46.03
-0.88
(-1.88%)
USD |
NASDAQ |
Jan 08, 16:00
46.01
-0.02
(-0.04%)
After-Hours: 20:00
QuidelOrtho SG&A Expense (Quarterly): 186.40M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Baxter International Inc | 754.00M |
| Repligen Corp | 75.61M |
| Teleflex Inc | 247.26M |
| Perspective Therapeutics Inc | 6.975M |
| Xtant Medical Holdings Inc | 19.38M |